
CAS Number94055-76-2
Synonyms(±)-[2-[[ p-(3-ethoxy-2-hydroxypropoxy)phenyl]carbamoyl]ethyl]dimethylsulfonium p-toluene sulfonate; MFCD00867604; Suplatast tosylate; UNII:C9J89787U1; Suplatast Tosilate; Suplatast (Tosilate)
Molecular FormulaC23H33NO7S2
Molecular Weight499.64
Purity≥98 (HPLC)%
Melting Point84-87ºC
Appearancepowder
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 94055-76-2 |
| Catalog No. | 2A-9012548 |
| Chinese Name | 甲磺司特 |
| Synonyms | (±)-[2-[[ p-(3-ethoxy-2-hydroxypropoxy)phenyl]carbamoyl]ethyl]dimethylsulfonium p-toluene sulfonate; MFCD00867604; Suplatast tosylate; UNII:C9J89787U1; Suplatast Tosilate; Suplatast (Tosilate) |
| Molecular Formula | C23H33NO7S2 |
| Molecular Weight | 499.64 |
| Purity | ≥98 (HPLC) |
| Melting Point | 84-87ºC |
| Appearance | powder |
| Water Solubility | Water solubility: completely dissolved; easily sol |
| Storage Condition | Store at RT |
| Application | Suplatast (IPD 1151T) tosylate is a Th2 cytokine inhibitor that can reduce the production of IL-2, IL-5 and IL-13, but has no effect on the production of IFN-γ. |
| PubChem ID | 329824551 |
| MDL Number | MFCD00867604 |
| SMILES | Cc1ccc(cc1)S([O-])(=O)=O.CCOCC(O)COc2ccc(NC(=O)CC[S+](C)C)cc2 |
| InChI | 1S/C16H25NO4S.C7H8O3S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3;1-6-2-4-7(5-3-6)11(8,9)10/h5-8,14,18H,4,9-12H2,1-3H3;2-5H,1H3,(H,8,9,10) |
| InChI Key | RYVJQEZJUFRANT-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| Hazard Symbols | Transport |
| MSDS | msds/12548_1_94055_76_2.pdf |
| Bioactivity | Suplatast tosilate(IPD 1151T) is a Th2 cytokine inhibitor that attenuates IL-2, IL-5 and IL-13 production and has no effect on IFN-γ production. IC50 value:Target: Th2 cytokine inhibitorSuplatast Tosilate acts as an immunoregulator that suppresses IgE production, eosinophil infiltration and histamine release. Suplatast Tosilate(IPD 1151T) exhibits antiasthmatic, anti-inflammatory and antifibrotic activity in vivo and is orally active. Related Catalog Signaling Pathways >> Immunology/Inflammation >> Interleukin Related Research Areas >> Inflammation/Immunology References [1]. Bito T, Kabashima R, Sugita K, Tokura Y. Angiolymphoid hyperplasia with eosinophilia on the leg successfully treated with T-helper cell 2 cytokine inhibitor suplatast tosilate. J Dermatol. 2011 Mar;38(3):300-2. doi: 10.1111/j.1346-8138.2010.00990.x. [2]. Shimizu S, Hattori R, Majima Y, Shimizu T. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats. Ann Otol Rhinol Laryngol. 2009 Jan;118(1):67-72. [3]. Furonaka M, Hattori N, Tanimoto T, Senoo T, Ishikawa N, Fujitaka K, Haruta Y, Yokoyama A, Kohno N. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 2009 Jan;328(1):55-61. [4]. Kurokawa et al (2001) Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo. Mediators Inflamm. 10 333. [5]. Furonaka et al (2009) Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. J.Pharmacol.Exp.Ther. 328 55. Chemical & Physical Properties Melting Point 84-87ºC Molecular Formula C23H33NO7S2 Molecular Weight 499.641 Exact Mass 499.169830 PSA 158.67000 LogP 3.72220 InChIKey RYVJQEZJUFRANT-UHFFFAOYSA-N SMILES CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1.Cc1ccc(S(=O)(=O)[O-])cc1 Storage condition Store at RT |
| Use of | Properties Articles323 Name Suplatast Tosylate Synonym More Synonyms Suplatast Tosilate Biological Activity Related Catalog Signaling Pathways >> Immunology/Inflammation >> Interleukin Related Research Areas >> Inflammation/Immunology References [3]. Furonaka M, Hattori N, Tanimoto T, Senoo T, Ishikawa N, Fujitaka K, Haruta Y, Yokoyama A, Kohno N. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 2009 Jan;328(1):55-61. [4]. Kurokawa et al (2001) Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo. Mediators Inflamm. 10 333. [5]. Furonaka et al (2009) Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. J.Pharmacol.Exp.Ther. 328 55. Chemical & Physical Properties Molecular Formula C23H33NO7S2 Exact Mass 499.169830 PSA 158.67000 LogP 3.72220 InChIKey RYVJQEZJUFRANT-UHFFFAOYSA-N Storage condition Store at RT |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Sulphadimethoxine | 122-11-2 | 2A-9012540 |
| Sulprophos | 35400-43-2 | 2A-9012541 |
| Sultamicillin tosylate | 83105-70-8 | 2A-9012542 |
| Sunepitron | 148408-65-5 | 2A-9012546 |
| Superoxide dismutase | 9054-89-1 | 2A-9012547 |
| Suprofen | 40828-46-4 | 2A-9012549 |
| Suramin sodium | 129-46-4 | 2A-9012550 |
| Surfomer | 71251-04-2 | 2A-9012551 |
| Suricainide | 85053-46-9 | 2A-9012552 |
| Susalimod | 149556-49-0 | 2A-9012553 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA